18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study-Reference-Cited by-同舟云学术

18F-FDG PET/CT Can Predict Survival of Advanced Hepatocellular Carcinoma Patients: A Multicenter Retrospective Cohort Study

Published:2016-10-27 Issue:5 Volume:58 Page:730-736
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Na Sae Jung,Oh Jin Kyoung,Hyun Seung Hyup,Lee Jeong Won,Hong Il Ki,Song Bong-Il,Kim Tae-Sung,Eo Jae Seon,Lee Sung Won,Yoo Ie Ryung,Chung Yong An,Yun Mijin

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference31 articles.

1. Global cancer statistics, 2012

2. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

3. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

4. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions;Bolondi;Semin Liver Dis.,2012

5. Development and validation of a new prognostic system for patients with hepatocellular carcinoma;Farinati;PLoS Med.,2016

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer;Transpathology;2024

2. Response to “Critique and Discussion of ‘Multicenter Evaluation of Frequency and Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of Skin-Absorbed Dose’”;Journal of Nuclear Medicine;2023-09-07

3. Comparison of Baseline⁶⁸Ga-FAPI and¹⁸F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib;Journal of Nuclear Medicine;2023-07-27

4. Imaging evaluation following transarterial radioembolization with yttrium-90 microspheres downstaging hepatocellular carcinoma: the first case in China;Quantitative Imaging in Medicine and Surgery;2023-04

5. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition);Liver Cancer;2023